REGN vs UGI · P/E 14, rev $14.34B vs P/E 12, rev $7.29B
Regeneron Pharmaceuticals Inc (REGN) versus UGI Corporation (UGI) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
UGI Corporation (UGI) is a utilities - regulated gas company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UGI revenue for 2025-09-30 was $7.29B. Net income was $678.0M. Revenue was up 1.1% from 2024-09-30 to 2025-09-30. UGI currently screens at market cap $7.21B and trailing P/E 11.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UGI currently screens at market cap $7.21B and trailing P/E 11.8.
Not investment advice. Open the REGN and UGI stock pages for the full models.
Not investment advice.